AstraZeneca scraps plan to expand UK vaccine sitenews2025-01-31T16:45:15+00:00January 31st, 2025|Endpoints News|
Celltrion looks to buy US facilities to sidestep potential Trump tariffs news2025-01-31T13:38:52+00:00January 31st, 2025|Endpoints News|
Rentschler exits cell and gene business due to low demand, will prioritize biologicsnews2025-01-30T16:25:55+00:00January 30th, 2025|Endpoints News|
Bright Green budgets $3.5B for new builds; European Commission opens biomanufacturing hubnews2025-01-30T16:05:21+00:00January 30th, 2025|Endpoints News|
Lonza looks to buy facilities and tech to boost service offeringsnews2025-01-29T16:19:17+00:00January 29th, 2025|Endpoints News|
Semaglutide, tirzepatide compounder hit with FDA warning letter news2025-01-28T18:38:28+00:00January 28th, 2025|Endpoints News|
Lantheus to buy radiopharma player Evergreen Theragnostics for $250M upfront news2025-01-28T12:12:17+00:00January 28th, 2025|Endpoints News|
Swarm Oncology launches with T cell therapy technology to treat solid tumorsnews2025-01-27T00:00:05+00:00January 27th, 2025|Endpoints News|
Takeda discontinues US supply of gout drug Uloricnews2025-01-24T17:03:44+00:00January 24th, 2025|Endpoints News|
Catalent to make CAR-T for Galapagos; Kindeva gets $129M for nerve agent antidotenews2025-01-23T16:18:20+00:00January 23rd, 2025|Endpoints News|
